Alterations in the Pattern of Collagen Deposition May Contribute to the Deterioration of Systolic Function in Hypertensive Patients With Heart Failure

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 89-96

  López, Begoña ^a   González, Arantxa ^a   Querejeta, Ramón ^b   Larman, Mariano ^c   Díez, Javier ^a,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Division of Hemodynamics   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARDIAC VOLUME; COLLAGEN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; SYSTOLE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VENTRICULAR FUNCTION, LEFT;

EID: 33745280899     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.01.077     Document Type: Article

References (27)

1. Lloyd-James D.M., Larson M.G., Leip E.P., et al. Lifetime risk for developing congestive heart failure. The Framingham Heart Study. Circulation 106 (2002) 3068-3072
2. Burlew B.S., and Weber K.T. Cardiac fibrosis as a cause of cardiac dysfunction. Herz 27 (2002) 92-98
3. Querejeta R., López B., González A., et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin. Circulation 110 (2004) 1263-1268
4. 1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 35 (2000) 1197-1202
5. Li H., Simon H., Bocan T.M., and Peterson J.T. MMP/TIMP expression in spontaneously hypertensive heart failure rats. the effect of ACE and MMP inhibition. Cardiovasc Res 46 (2000) 298-306
6. Mujumdar V.S., and Tyagi S.C. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertens 17 (1999) 261-270
7. Laviades C., Varo N., Fernández J., et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 98 (1998) 535-540
8. Hirono O., Fatema K., Nitobe J., et al. Long-term effects of benidipine hydrochloride on severe left ventricular hypertrophy and collagen metabolism in patients with essential hypertension. J Cardiol 39 (2002) 195-204
9. Li-Saw-Hee F.L., Edmunds E., Blann A.D., Breevers D.G., and Lip G.Y. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and antihypertensive therapy. Int J Cardiol 75 (2000) 43-47
10. Iwanaga Y., Aoyama T., Kihara Y., Onozawa Y., Yoneda T., and Sasayama S. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 39 (2002) 1384-1391
11. Peterson J.T., Hallak H., Johnson L., et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103 (2001) 2303-2309
12. Ho K.L., Pinsky J.L., Kannel W.B., and Levy D. The epidemiology of heart failure. The Framingham Study. J Am Coll Cardiol 22 Suppl A (1993) 6A-13A
13. Querejeta R., Varo N., López B., et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101 (2000) 1729-1735
14. Ganau A., Devereux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19 (1992) 1550-1558
15. Lauer M.S., Larson M.G., and Levy D. Gender-specific reference M-mode values in adults. population-derived values with consideration of the impact of height. J Am Coll Cardiol 26 (1995) 1039-1046
16. Douglas P.S., Reichek N., Plappert T., Muhammad A., and St. John Sutton M.G. Comparison of echocardiographic methods for assessment of left ventricular shortening and wall stress. J Am Coll Cardiol 9 (1987) 945-951
17. Karl J., Borgya A., Gallusser A., et al. Development of a novel, N-terminal-pro-BNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest 59 Suppl 230 (1995) 177-181
18. Polyakova V., Hein S., Kostin S., Ziegelhoeffer T., and Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 44 (2004) 1609-1618
19. Fielitz J., Leuschner M., Zurbrügg H.R., et al. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J Mol Med 12 (2004) 809-820
20. Siwik D.A., and Colucci W.S. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 9 (2004) 43-51
21. Spinale F.G. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. Circ Res 91 (2002) 1082-1084
22. Baicu C.F., Stroud J.D., Livesay V.A., et al. Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol 284 (2003) H122-H132
23. Kim H.E., Dalal S.S., Young E., Legato M.J., Weisfeldt M.L., and D'Armiento J. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 106 (2000) 857-866
24. Coker M.L., Doscher M.A., Thomas C.V., Galis Z.S., and Spinale F.G. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am J Physiol Heart Circ Physiol 277 (1999) H777-H787
25. Janicki J.S., and Brower G.L. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail 8 Suppl (2002) S319-S325
26. Linzbach A.J. Hypertrophy, hyperplasia and structural dilatation of the human heart. Adv Cardiol 18 (1976) 1-14
27. Pearlman E.S., Weber K.T., Janicki J.S., Pietra G.G., and Fishman A.P. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 46 (1982) 158-164